blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2510930

EP2510930 - Nanoparticles comprising half esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.09.2013
Database last updated on 31.08.2024
Most recent event   Tooltip20.09.2013Application deemed to be withdrawnpublished on 23.10.2013  [2013/43]
Applicant(s)For all designated states
Bionanoplus, S.L.
Polígono Mocholí
Plaza Cein, 5 - nave B14
31110 Noáin- Navarra / ES
[N/P]
Former [2012/42]For all designated states
Bionanoplus, S.L.
Poligono Mocholi Plaza Cein, 5 - nave B14
31110 Noain- Navarra / ES
Inventor(s)01 / Salman, Hesham H.A.
Bionanoplus, S.L.
Polígono Mocholí Plaza Cein
5 - nave B14
31110 Noáin - Navarra / ES
02 / Goñi Azcarate, Izaskun
Arbizu, 13 - 4º izda
31008 Pamplona / ES
 [2012/42]
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2012/42]ABG Patentes, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
Application number, filing date11382115.115.04.2011
[2012/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2510930
Date:17.10.2012
Language:EN
[2012/42]
Search report(s)(Supplementary) European search report - dispatched on:EP07.10.2011
ClassificationIPC:A61K35/00, C08J3/07
[2012/42]
CPC:
B82Y5/00 (EP,US); A61K9/5138 (US); A23L5/00 (EP,US);
A61K31/00 (EP,US); A61K8/11 (EP,US); A61K8/8164 (EP,US);
A61K9/0014 (EP,US); A61K9/006 (EP,US); A61K9/5146 (EP,US);
A61K9/5192 (EP,US); A61P17/14 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61Q19/00 (EP,US); C08F265/06 (EP,US);
C08J3/07 (EP,US); C08J3/126 (EP,US); C08J3/14 (EP,US);
C08L33/064 (US); A23L33/125 (EP,US); A61K2800/10 (EP,US);
A61K2800/412 (EP,US); A61Q5/12 (EP,US); C08J2329/10 (EP,US);
C08J2335/08 (EP,US); Y10T428/2982 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/42]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Nanopartikel mit Halbestern aus Poly(Methylvinylether-Co-Maleinsäureanhydrid) und Verwendungen davon[2012/42]
English:Nanoparticles comprising half esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof[2012/42]
French:Nanoparticules comportant des semi-esters de poly (méthyl vinyl éther-co-maléique anhydride) et leurs utilisations[2012/42]
Examination procedure18.04.2013Application deemed to be withdrawn, date of legal effect  [2013/43]
04.06.2013Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2013/43]
Fees paidPenalty fee
Additional fee for renewal fee
30.04.201303   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US4164562  (HUNTER LEROY [US], et al) [X] 5-10 * example 1 *;
 [XD]EP0451390  (PHARMETRIX CORP [US]) [XD] 5-9 * example 11 *;
 [A]EP1752141  (INST CIENTIFICO TECNOL NAVARRA [ES]) [A] 1-15* claim - *
by applicantEP0451390
    - ILLUM, L. ET AL., "Chitosan as a novel nasal delivery system for vaccines", ADV DRUG DELIV REV, (2001), vol. 51, no. 1-3, doi:doi:10.1016/S0169-409X(01)00171-5, pages 81 - 96, XP001115064

DOI:   http://dx.doi.org/10.1016/S0169-409X(01)00171-5
    - READ, R.C. ET AL., "Effective nasal influenza vaccine delivery using chitosan", VACCINE, (2005), vol. 23, no. 35, doi:doi:10.1016/j.vaccine.2005.04.021, pages 4367 - 4374, XP004973238

DOI:   http://dx.doi.org/10.1016/j.vaccine.2005.04.021
    - MILLS, K.H. ET AL., "Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a", INFECT IMMUN, (2003), vol. 71, no. 2, doi:doi:10.1128/IAI.71.2.726-732.2003, pages 726 - 732, XP002465928

DOI:   http://dx.doi.org/10.1128/IAI.71.2.726-732.2003
    - FINNE, U., K. RONKKO, A. URTTI, "Timolol release from matrices of monoesters ofpoly(vinyl methyl ether-maleic anhydride): effects ofpolymer molecular weight and a basic additive", J PHARM SCI, (1991), vol. 80, no. 7, pages 670 - 673
    - FINNE, U., V. VAISANEN, A. URTTI, "Modification of ocular and systemic absorption of timololfrom ocular inserts by a buffering agent and a vasoconstrictor", INT J PHARM, (1990), vol. 65, pages 19 - 27
    - ARBOS, P. ET AL., J CONTROL RELEASE, (2003), vol. 89, no. 1, pages 19 - 30
    - ARBOS, P. ET AL., "Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines", J CONTROL RELEASE, (2004), vol. 96, no. 1, doi:doi:10.1016/j.jconrel.2004.01.006, pages 55 - 65, XP004500732

DOI:   http://dx.doi.org/10.1016/j.jconrel.2004.01.006
    - KOCKISCH, S. ET AL., "Mucoadhesive, triclosan-loaded polymer microspheresfor application to the oral cavity: preparation and controlled release characteristics", EUR J PHARM BIOPHARM, (2005), vol. 59, no. 1, pages 207 - 216
    - KOCKISCH ET AL., J PHARM SCI, (2003), vol. 92, no. 8, pages 1614 - 1623
    - MARCHAIS, H. ET AL., "Entrapment efficiency and initial release ofphenylbutazone from nanocapsules prepared from different polyesters", DRUG DEV IND PHARM, (1998), vol. 24, no. 9, pages 883 - 888
    - ARBOS, P. ET AL., "Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles", INT J PHARM, (2002), vol. 242, no. 1-2, pages 129 - 136, XP008073994
    - SALMAN, H.H. ET AL., "Bioadhesive mannosylated nanoparticles for oral drug delivery", J NANOSCI NANOTECHNOL, (2006), vol. 6, no. 9-10, pages 3203 - 3209
    - ERIKA ROSA MARIA KEDOR-HACKMANN ET AL., "First-derivative ultraviolet spectrophotometric and high performance liquid chromatographic determination of ketoconazole in pharmaceutical emulsions", BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, (2006), vol. 42, no. 1, pages 91 - 98
    - GEHAN BALATA, M.M., RANIA ABU BAKERA, "Improvement of solubility and dissolution properties of ketoconazole by solid dispersions and inclusion complexes", ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, (2010), vol. 5, no. 1, pages 1 - 12
    - KWON, KIM, "In vitro skin permeation ofmonoolein nanoparticles containing hydroxypropyl beta-cyclodextrin/minoxidil complex", INT J PHARM, (2010), vol. 392, no. 1-2, pages 268 - 273, XP027044533
    - TAKEUCHI, H.H. ET AL., "Mucoadhesive nanoparticulate systems for peptide drug delivery", ADV. DRUG DEIV. REV., (2001), vol. 47, no. 1, doi:doi:10.1016/S0169-409X(00)00120-4, pages 39 - 54, XP008117909

DOI:   http://dx.doi.org/10.1016/S0169-409X(00)00120-4
    - PEH, WONG, "Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties", J PHARM PHARM SCI, (1999), vol. 2, no. 2, pages 53 - 61
    - PERIOLI, L. ET AL., "Novel mucoadhesive buccal formulation containing metronidazole for the treatment ofperiodontal disease", J CONTROL RELEASE, (2004), vol. 95, no. 3, doi:doi:10.1016/j.jconrel.2003.12.018, pages 521 - 533, XP004496391

DOI:   http://dx.doi.org/10.1016/j.jconrel.2003.12.018
    - KIM, J.C., M.D. KIM, J MICROBIOL BIOTECHNOL, (2007), vol. 17, no. 12, pages 1965 - 1969
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.